Transcript Ambion, Inc.
NAT Testing in Solid Tissues and Organs: A Pre-analytical Solution for Nucleic Acid Stabilization
Cindy WalkerPeach, Ph.D.
Copyright © 2007 Asuragen, Inc
Ambion Diagnostics Becomes Asuragen!
Ambion Research Products Division Purchased by Applied Biosystems Group (NYSE: ABI) for $273M March 2, 2006 Ambion, Inc.
Formed 1989 Ambion Diagnostics Division Formed 2000 Ambion Services Division Formed 2005 Asuragen, Inc.
Ambion Diagnostics Ambion Services Key Ambion R&D Scientists and Executive Team
Copyright © 2007 Asuragen, Inc
RNARetain
™
Pre-analytical Solution • Overview • Applications • Examples • Conclusions
Copyright © 2007 Asuragen, Inc
RNARetain Overview
• Versatile, non-toxic, non-organic solution for preservation of nucleic acids by inactivating nucleases to prevent degradation of RNA/DNA • Stabilizes nucleic acids at room temperature, without requirement of dry ice or liquid nitrogen, thereby allowing biological samples to be shipped on wet ice or at ambient temperatures • Compatible with all downstream RNA extraction methods • Based on formulation widely used in life science research (RNA
later
- Ambion, Inc.) • Covered by US patent: 6,204,375 and WW equivalents Copyright © 2007 Asuragen, Inc
RNARetain - cGMP Traceability
• Manufactured under QSR 21 CFR Part 820 guidelines to ensure lot-to-lot consistency critical for reagents used in clinical specimen collection and storage for downstream RNA extraction and molecular analysis • Compatibility with major extraction procedures and molecular analysis techniques will allow end-user to qualify reagent for use in specific downstream applications • cGMP traceability provides consistent performance in end user’s hands Copyright © 2007 Asuragen, Inc
Selected Publications
• Development and validation of a method for using breast core needle biopsies for gene expression microrarray analyses Matthew Ellis,
et al
.
Clin Cancer Res. 2002, 8:1155-1166
• The effect of sample degradation and RNA stabilization on classical swine fever virus RT-PCR and ELISA methods Stuart D. Blacksell, Syseng Khounsy and Harvey A. Westbury.
J. Vir Methods. 2004, 118(1):33-37
• Viral infectivity is maintained by an RNA protection buffer C. Uhlenhaut and M. Kracht.
J. Virol Methods. 2005, 128(1-2):189-91
• Prognostic gene expression signatures can be measured in tissues collected in RNAlater preservative Dondapati Chowdary,
et al
.
JMD. 2006, Vol. 8, No. 1
• Currently there are over 1,000 citations since Jan 2001 in HighWire Press: http://Highwire.Stanford.edu
Copyright © 2007 Asuragen, Inc
Unmet Clinical Need…………
Easy and Safe Sample Acquisition “Freezes” mRNA and microRNA Expression Profiles Long-Term Cell/ Tissue Banking
Clinical
Virus Preservation Molecular Isolation (RNA/DNA) Convenient Sample Transport
Clinical Research, Tissue/Cell Banking, Expression Profiling Services, Molecular Diagnostics
Copyright © 2007 Asuragen, Inc
Intracellular RNA Preservation
5E+5 MCF-7 Breast Tissue Cells
Sample RNARetain 260/280 28S:18S
2.02
1.75
RIN
10.00
Flash Frozen RNARetain Flash Frozen
2.01
1.72
1.87
1.20
1.30
1.45
9.65
9.15
8.90
Flash Freeze RNARetain
Flash Freeze Or RNARetain x4
mir
Vana ™ or Trizol ® Extraction Nanodrop ® Agilent Bioanalyzer Copyright © 2007 Asuragen, Inc
RNARetain preserves the quality of intracellular RNA to the same extent as the currently established standard of flash-freezing
qRT-PCR Reproducibility
5E+5 MCF-7 Cells In RNARetain 1E+3 HCV1b ARQ Process Control
mir
Vana Extraction HCV1b (process con) and TBP (internal con) qRT-PCR at 40ng sample input x3 x5
Sample # 260/280 28S:18S RIN 1
1.96
1.73
9.87
2 3
1.99
2.09
1.83
1.77
9.97
9.90
4 5
1.98
1.97
1.63
1.77
9.90
9.93
40 45 35 30 25 20 43 41 39 37 35 33 31 29 27 15 25 1 2 3 4 5
Sample Number Reproducible RNA quality and qRT-PCR amplification efficiency is achieved for intracellular RNA extracted from RNARetain preserved cells
Copyright © 2007 Asuragen, Inc TBP ARQ HCV1b
Armored RNA
®
Recovery from RNARetain
1E+7 HCV1b ARQ + or - RNARetain RNA Isolation (Trizol or
mir
Vana Kit) HCV1b qRT-PCR x3 x3 40 35 30 25 20 15
+ + RNARetain
mir
Vana Trizol Process Rep 1 Process Rep 2 Process Rep 3
Pseudo-viral particles can be preserved in and extracted from RNARetain in a reproducible manner
Copyright © 2007 Asuragen, Inc
RNARetain Data Summary
• Preserves quality of intracellular RNA to same extent as flash-freezing • Does not interfere with reproducibility of intracellular RNA extraction and analysis methods • Effective for storage and preservation of viral RNA as indicated by compatibility with Armored RNA Copyright © 2007 Asuragen, Inc
Case Study: C N n=7 Ch n=7 Combination of two microRNAs can be used to distinguish normal, chronic pancreatitis, and carcinoma samples Copyright © 2007 Asuragen, Inc
Analysis of FNA Specimens
Endoscopic microdissection of pancreatic mass (EU-FNA) Preservation in RNARetain RNA Isolation microRNA expression profiling (qRT-PCR)
Signal ratios for two miRNAs showing differential expression specific to cancerous (ca) or normal (N) tissue are maintained in RNARetain (FNA samples)
6 12 2 8 -2 4 -6 0 -10 -4 -14
Ca FNA
n=7
Ca N Frozen
n=2 n=2
RNARetain preserves miRNA signatures for downstream molecular profiling
-8
Ca Frozen N
n=10 n=7 Frozen tissues from Szafranska et al.
Copyright © 2007 Asuragen, Inc
Closing Remarks
• RNARetain is a pre-analytical solution which stabilizes intracellular RNA in cells and solid tissues for downstream extraction and molecular characterization • RNARetain is compatible with Armored RNA, illustrating potential utility in collection and storage of viral-infected tissues, thus eliminating the need for immediate processing or flash freezing • Next step will be to identify beta test sites to evaluate clinical utility of RNARetain for collection and transport of viral-infected tissue specimens • Agendia, B.V.
Used in conjunction with MammaPrint of breast cancer recurrence ® 70 gene expression signature which predicts the risk Received US FDA approval Feb 6, 2007 Copyright © 2007 Asuragen, Inc